The book "Synthesis and Development of Drugs for Multiple Sclerosis" offers a comprehensive analysis of current approaches to the synthesis and development of medications for the treatment of multiple sclerosis, an autoimmune disease that affects the central nervous system. The condition leads to demyelination of the axons of neurons, which impairs normal nerve transmission and is considered a primary cause of neurological disabilities in adults and adolescents. The book highlights the challenges associated with the diagnosis and treatment of this complex disease and provides an overview of the various types of multiple sclerosis, as well as the diagnostic criteria used to differentiate the condition. By analyzing common medications, it conveys a deeper understanding of therapeutic options and their development.